Get the Stockscreener App
11.81
1.34%
-0.16
After Hours:
11.81
Clearpoint Neuro Inc stock is traded at $11.81, with a volume of 147.99K.
It is down -1.34% in the last 24 hours and down -19.50% over the past month.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
See More
Previous Close:
$11.97
Open:
$11.84
24h Volume:
147.99K
Relative Volume:
0.55
Market Cap:
$333.87M
Revenue:
$30.43M
Net Income/Loss:
$-18.15M
P/E Ratio:
-17.12
EPS:
-0.69
Net Cash Flow:
$-9.08M
1W Performance:
-0.67%
1M Performance:
-19.50%
6M Performance:
-4.53%
1Y Performance:
+112.79%
1-Day Range:
$11.59
$12.01
1-Week Range:
$11.59
$12.62
52-Week Range:
$5.11
$19.22
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Name
Clearpoint Neuro Inc
Sector
Industry
Phone
(949) 900-6833
Address
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
11.81 | 336.07M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Oct-24-23 | Initiated | Stifel | Buy |
| Feb-16-23 | Resumed | B. Riley Securities | Buy |
| Apr-05-22 | Resumed | B. Riley Securities | Buy |
| Mar-18-21 | Initiated | Lake Street | Buy |
| Jul-17-20 | Initiated | B. Riley FBR | Buy |
View All
Clearpoint Neuro Inc Stock (CLPT) Latest News
Northern Trust Corp Reduces Stock Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Millennium Management LLC Acquires 13,866 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro Inc (CLPT) Trading Down 3.83% on May 28 - GuruFocus
Where are the Opportunities in (CLPT) - news.stocktradersdaily.com
ClearPoint Neuro Approves Key Proposals at Annual Meeting - TipRanks
ClearPoint Neuro Inc. (CLPT) Stock Analysis: A Potential 138% Upside in the Medical Device Sector - DirectorsTalk Interviews
ClearPoint Neuro Updates Director Compensation Plan - TipRanks
Oberland Capital’s Investment in ClearPoint Neuro - Global Legal Chronicle
ClearPoint Neuro targets 15–20 new site activations in 2025 while advancing cell and gene therapy initiatives - MSN
Q2 Earnings Estimate for ClearPoint Neuro Issued By B. Riley - Defense World
ClearPoint Neuro First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
ClearPoint Neuro’s Earnings Call: Growth Amid Challenges - TipRanks
(CLPT) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q1 2025 Earnings Call Transcript - Insider Monkey
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil - TradingView
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Tops Revenue Estimates - MSN
ClearPoint Neuro (CLPT) Confirms Fiscal Year 2025 Revenue Foreca - GuruFocus
ClearPoint Neuro Reports Record Q1 2025 Revenue - TipRanks
ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges - Yahoo Finance
ClearPoint Neuro (CLPT) Reports Strong Q1 Growth and Strategic A - GuruFocus
Clearpoint Neuro earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Earnings call transcript: ClearPoint Neuro’s Q1 2025 revenue beats forecast By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) Reports Strong Start to FY25 with Record Revenue | CLPT Stock News - GuruFocus
Clearpoint Neuro Inc reports results for the quarter ended March 31Earnings Summary - TradingView
ClearPoint Neuro Reports First Quarter 2025 Results | CLPT Stock News - GuruFocus
Earnings call transcript: ClearPoint Neuro’s Q1 2025 revenue beats forecast - Investing.com Australia
ClearPoint Neuro, Inc. SEC 10-Q Report - TradingView
ClearPoint Neuro Reports Q1 Earnings: Revenue Beat, EPS Miss, Company Affirms FY25 Guidance - Benzinga
CLEARPOINT NEURO Earnings Results: $CLPT Reports Quarterly Earnings - Nasdaq
ClearPoint Neuro Inc (CLPT) Reports Q1 Revenue of $8.5M, Exceedi - GuruFocus
ClearPoint Neuro Reports First Quarter 2025 Results - ACCESS Newswire
ClearPoint Neuro Breaks Revenue Records as Brain Navigation Technology Sales Soar 104% in Q1 2025 - Stock Titan
ClearPoint Neuro Reports Record Q1 2025 Revenue Growth - TipRanks
Clearpoint Neuro Inc QTRLY Loss Per Share $0.22 - marketscreener.com
ClearPoint Neuro Announces Investment of up to $110 Million by O - GuruFocus
Wall Street Analysts Believe ClearPoint Neuro (CLPT) Could Rally 102.86%: Here's is How to Trade - Nasdaq
ClearPoint Neuro secures up to $105 million financing By Investing.com - Investing.com Nigeria
ClearPoint Neuro Secures $110 Million Investment Deal - TipRanks
ClearPoint Neuro secures up to $105 million financing - Investing.com
ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing | CLPT Stock News - GuruFocus
ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing - ACCESS Newswire
ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Report Preview: Wha - GuruFocus
Tower Research Capital LLC TRC Takes $93,000 Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - The AM Reporter
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Bought by Barclays PLC - Defense World
ClearPoint Neuro (CLPT) to Release Earnings on Tuesday - Defense World
(CLPT) Technical Data - news.stocktradersdaily.com
After Leaping 31% ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Are Not Flying Under The Radar - simplywall.st
ClearPoint Neuro Stock: Fundamentals Continue To Strengthen (NASDAQ:CLPT) - Seeking Alpha
ClearPoint Neuro (CLPT) Expands Use of Prism Neuro Laser with FD - GuruFocus
ClearPoint Neuro, Together with its Partner Clinical Laserthermi - GuruFocus
Clearpoint Neuro Inc Stock (CLPT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.36%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):